Skip to content Skip to footer
Adalimumab-Aaty: Benefits, Reviews, Info, Side Effects!
Rx Details
Adalimumab-Aaty
Adalimumab, Humira, Amjevita, Cyltezo, Hadlima
Adalimumab-Aaty
Prescription
Biologic
Drugs
Biological Product
reduces inflammation, treats autoimmune conditions, improves joint function, decreases pain, slows disease progression, enhances quality of life
Abdominal Pain, Allergic Reactions, Back Pain, Cough, Cytopenias, Demyelinating Disease, Dizziness, Fatigue, Headache, Heart Failure, Hypertension, Increased Liver Enzymes, Injection Site Reactions, Lupus-Like Syndrome, Malignancies, Nausea, Rash, Serious Infections, Sinusitis, Upper Respiratory Infections, Urinary Tract Infections
Adalimumab-Aaty is a biosimilar to adalimumab, which is a medication used to treat various autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, and ulcerative colitis, among others. The dosage of adalimumab can vary depending on the condition being treated, the patient’s response to the medication, and other individual factors. For many conditions, the typical starting dosage of adalimumab is 40 mg administered subcutaneously every other week. However, some conditions may require a different dosing regimen, such as an initial loading dose or more frequent dosing. It’s important to follow the specific dosing instructions provided by a healthcare professional, as they will tailor the dosage to the individual’s needs. Always consult with a healthcare provider for the most accurate and personalized dosage information.
Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, uveitis
Adalimumab-Aaty has a favorable safety profile.
No Interactions Reported
$1,000 – $2,000
$5,306.99

A Synopsis of

Adalimumab-Aaty

Adalimumab-Aaty is a medication that belongs to a class of drugs known as tumor necrosis factor (TNF) inhibitors. It is used to treat a variety of inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis.

Adalimumab-Aaty works by targeting and blocking TNF, a protein in the body that plays a key role in the inflammatory response. By inhibiting TNF, this medication helps to reduce inflammation and alleviate symptoms associated with these conditions.

It is important to follow your healthcare provider’s instructions when taking Adalimumab-Aaty. This medication is typically administered as an injection under the skin, and the frequency of dosing may vary depending on the condition being treated. Your healthcare provider will determine the appropriate dosage and schedule for you based on your individual needs.

As with any medication, Adalimumab-Aaty may cause side effects. Common side effects may include injection site reactions, headache, and upper respiratory infections. It is important to report any side effects to your healthcare provider, as they may indicate the need for a dosage adjustment or a change in treatment.

Before starting Adalimumab-Aaty, be sure to inform your healthcare provider about any other medications you are taking, as well as any medical conditions you may have. This will help ensure that Adalimumab-Aaty is safe and appropriate for you.

Overall, Adalimumab-Aaty is a valuable treatment option for individuals with inflammatory conditions. By working to reduce inflammation and alleviate symptoms, this medication can help improve quality of life for those living with these chronic conditions.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN